Procter & Gamble shares Q2 results via Reg FD 8-K
The Procter & Gamble Company filed a current report to share that it issued a press release announcing its second quarter results and held a related conference call.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
The Procter & Gamble Company filed a current report to share that it issued a press release announcing its second quarter results and held a related conference call. The company is also making available a set of informational slides that were referenced on the call and posted on its website.
This report is furnished under Regulation FD, which is meant to ensure all investors have access to the same information at the same time. The filing also lists the company’s common stock and various outstanding debt securities that are registered for trading on the New York Stock Exchange.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Procter & Gamble (PG) disclose in this 8-K filing?
The company disclosed that it issued a press release announcing second quarter results, hosted a conference call about those results, and provided related informational slides.
Which quarter’s results are referenced in Procter & Gamble’s (PG) 8-K?
The 8-K refers to Procter & Gamble’s second quarter results, which were discussed in a press release and conference call.
What exhibits did Procter & Gamble (PG) include with this 8-K?
Exhibit 99.1 contains informational slides provided by the company dated January 22, 2026, and Exhibit 104 is the cover page interactive data file embedded in the Inline XBRL document.
Under which item of Form 8-K did Procter & Gamble (PG) furnish this information?
The information was furnished under Item 7.01, Regulation FD Disclosure, with additional exhibit details provided under Item 9.01.
Which Procter & Gamble (PG) securities are listed as registered on the NYSE?
The filing lists Procter & Gamble common stock without par value and multiple series of notes, including 0.110% Notes due 2026, 3.25% EUR Notes due 2026, 4.875% EUR Notes due May 2027, and various other notes maturing between 2028 and 2045.
Does this Procter & Gamble (PG) 8-K contain the actual second quarter financial figures?
No, this report describes the press release, conference call, and slides about second quarter results but does not include the detailed financial figures in the text provided.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 22, 2026
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices and zip code) | ||||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 - Regulation FD Disclosure
On January 22, 2026, The Procter & Gamble Company (the "Company") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
Item 9.01 - Financial Statements and Exhibits
(d): The following exhibits are being filed herewith:
| Exhibit No. | Description | |||||||
| 99.1 | Informational Slides Provided by The Procter & Gamble Company dated January 22, 2026. | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 22nd day of January, 2026.
| THE PROCTER & GAMBLE COMPANY | ||||||||
By: | /s/ Sandra T. Lane | |||||||
Name: | Sandra T. Lane | |||||||
Title: | Assistant Secretary | |||||||
INDEX TO EXHIBIT(S)
99.1 - Informational Slides Provided by The Procter & Gamble Company dated January 22, 2026.